Read more on this story here: [ Ссылка ]
Quebec-based biotechnology company Medicago has developed a plant-derived vaccine for COVID-19 that is now undergoing early-stage clinical trials.
The Phase I trials will evaluate the safety of the plant-based vaccine in a cohort of 180 healthy men and women between the ages of 18 and 55. The first trials began in Quebec City on Monday.
For more Life Science News stories, visit: [ Ссылка ]
Receive weekly news and webinar updates right in your inbox: [ Ссылка ]
Listen live and interact with featured speakers on our upcoming Life Science webinars: [ Ссылка ]
